TCIM
HSTO

TIAA CREF Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

TIAA CREF Investment Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-709
Closed -$832K – 3147
2018
Q1 		$832K Sell
709
-375
-35% -$414K ﹤0.01% 2522
2017
Q4 		$1M Buy
1,084
+240
+28% +$222K ﹤0.01% 2459
2017
Q3 		$926K Buy
844
+496
+143% +$564K ﹤0.01% 2558
2017
Q2 		$400K Buy
+348
New +$424K ﹤0.01% 2961
2014
Q2 		– Sell
-81
Closed -$132K – 3199
2014
Q1 		$132K Buy
81
+26
+47% +$54.4K ﹤0.01% 3096
2013
Q4 		$70K Hold
55
– – ﹤0.01% 3116
2013
Q3 		$110K Buy
+55
New +$102K ﹤0.01% 3073

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

TIAA CREF Investment Management's HSTO Position: Q2 2018 in Review

TIAA CREF Investment Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 709 shares — an estimated $832K sold.

TIAA CREF Investment Management first reported a position in HSTO in Q3 2013 and held it in 7 quarters. The position peaked at $1M in Q4 2017. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • TIAA CREF Investment Management reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 709 Histogen Inc. Common Stock shares in Q2 2018, an estimated $832K.
  • TIAA CREF Investment Management first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 7 quarters.
  • TIAA CREF Investment Management's Histogen Inc. Common Stock position peaked at $1M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.